Cas:19912-84-6 Chamigrenal manufacturer & supplier

Chemical Name:Chamigrenal

CAS.NO:19912-84-6

Synonyms:Chamigrenal

Molecular Formula:C₁₅H₂₂O

Molecular Weight:218.33500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:320.5ºC at 760 mmHg

Density:0.97g/cm3

Index of Refraction:1.507

PSA:17.07000

Exact Mass:218.16700

LogP:4.04830

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Chamigrenal chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Chamigrenal physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Chamigrenal Use and application,Chamigrenal technical grade,usp/ep/jp grade.

Related News: The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said. Chamigrenal manufacturer The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said. Chamigrenal supplier At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. Chamigrenal vendor In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. Chamigrenal factory The European Medicines Agency did not say how many shots were affected, but Reuters has reported it involves millions of doses, making it harder for J&J to meet a target of delivering 55 million to Europe by end of June.